Literature DB >> 150112

Role of fibrinolysis in development of hyaline membrane disease in newborn rabbits.

K Sueishi, K Tanaka, T Oda.   

Abstract

The role of fibrinolysis in the pathogenesis of hyaline membrane disease was studied in newborn rabbits at 28- or 29-day gestation. Hyaline membrane was recognized in the lungs of rabbits that were exposed to intrauterine hypoxia and received trans-4-aminomethylcyclohexane carboxylic acid (t-AMCHA), a plasmin inhibitor found to cause a marked decrease in the fibrinolytic activity of lung extracts. In the newborn rabbits subjected to intrauterine hypoxia alone, surface activity of lung extracts was reduced, but hyaline membrane was not seen. By immunofluorescent examination the hyaline membrane was found to be rich in fibrinogen and its derivatives. Electron microscopic examination revealed that they contained various amounts of cellular debris, bundles of fibrils and electron-dense, finely granular deposits and polymerized fibrin with 230 A periodicity. Disintegration of pulmonary epithelial cells was also seen. These findings indicate that diminished fibrinolytic activity of lung tissue contributes to intra-alveolar accumulation of fibrinogen, fibrin and their degradation products, thereby bringing about morphological and physiological disintegration of the terminal airways.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 150112     DOI: 10.1007/bf00427363

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  25 in total

Review 1.  Hyaline membrane disease.

Authors:  P M Farrell; M E Avery
Journal:  Am Rev Respir Dis       Date:  1975-05

2.  PATHOPHYSIOLOGY OF RESPIRATORY DISTRESS IN NEWBORN LAMBS. CIRCULATORY, BIOCHEMICAL, AND PATHOLOGICAL CONSIDERATIONS.

Authors:  M STAHLMAN; V S LEQUIRE; W C YOUNG; R E MERRILL; R T BIRMINGHAM; G A PAYNE; J GRAY
Journal:  Am J Dis Child       Date:  1964-10

3.  A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY.

Authors:  H F CLARK; C C SHEPARD
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

4.  PRELIMINARY REPORT. THE PULMONARY HYPOPERFUSION SYNDROME.

Authors:  J CHU; J A CLEMENTS; E COTTON; M H KLAUS; A Y SWEET; M A THOMAS; W H TOOLEY
Journal:  Pediatrics       Date:  1965-05       Impact factor: 7.124

5.  Organ distribution of fibrinolytic activity in man.

Authors:  H SANDBERG; M REZAI; T T BANGAYAN; S BELLET; L J FEINBERG; S HUNTER
Journal:  J Lab Clin Med       Date:  1963-04

6.  Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues.

Authors:  T ASTRUP; O K ALBRECHTSEN
Journal:  Scand J Clin Lab Invest       Date:  1957       Impact factor: 1.713

7.  Plasminogen in the prevention of hyaline membrane disease.

Authors:  C M Ambrus; D H Weintraub; T S Choi; B Eisenberg; H P Staub; N G Courey; R J Foote; D Goplerud; R V Moesch; M Ray; I D Bross; O S Jung; I B Mink; J L Ambrus
Journal:  Am J Dis Child       Date:  1974-02

8.  Serum trypsin inhibitory capacity and the idiopathic respiratory distress syndrome.

Authors:  H E Evans; S Keller; I Mandl
Journal:  J Pediatr       Date:  1972-09       Impact factor: 4.406

9.  Biochemical development of surface activity in mammalian lung. IV. Pulmonary lecithin synthesis in the human fetus and newborn and etiology of the respiratory distress syndrome.

Authors:  L Gluck; M V Kulovich; A I Eidelman; L Cordero; A F Khazin
Journal:  Pediatr Res       Date:  1972-02       Impact factor: 3.756

10.  The influence of intravascular fluid volume on the permeability of newborn and adult mouse lungs to ultrastructural protein tracers.

Authors:  E E Schneeberger; M J Karnovsky
Journal:  J Cell Biol       Date:  1971-05-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.